Lazomis QI
Profile
Preview mode — sample data only. Sign in to use this tool with live projects.Sign in to use this tool

Polypharmacy Review Audit

Preview Audit · Cycle 1 · NICE NG5: Medicines optimisation; NHS structured medication review guidance; STOPP/START criteria version 3

Preview · sample data

Patient and review context

Use a pseudonymised audit identifier — do not enter patient-identifiable data

Medication burden

High-risk medicine classes

Tick each class present in the patient's regular medication

Anticoagulants
Opioids
Insulin
Hypoglycaemic agents (non-insulin)
Anticholinergic medicines
Sedatives / hypnotics
NSAIDs
Duplicate medicines identified

Structured review components

NICE NG5, NHS structured medication review guidance and STOPP/START v3

Structured medication review completed
Dose appropriateness reviewed
Drug interactions reviewed
Hepatic considerations reviewed
Deprescribing opportunities identified
Pharmacy review completed
Consultant review completed
Medication changes documented
Rationale for changes documented
Monitoring plan documented
GP communication documented
Patient counselling documented

Core compliance criteria

Indication documented for regular medicines
Medicines reconciliation completed
Renal dosing reviewed / renal function documented
Falls risk considered where relevant
Patient/carer involved in the review
STOPP/START considered where appropriate
Action plan documented
Follow-up need assessed/documented

Outcome and comments

Project-level custom fields are configured in Project Setup.